New CDC data reveal less than a third of people diagnosed with Hepatitis C receive timely treatment for the deadly, yet curable, infection : media statement embargoed until: August 9, 2022, 1:00 PM ET

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Large gaps in treatment persist nearly a decade after a highly effective cure for hepatitis C was approved.
  
  A new CDC Vital Signs report finds that too few people diagnosed with hepatitis C are being treated, despite availability of medications capable of curing this viral infection. According to CDC’s estimates:
  
  • Overall, less than 1 in 3 people with health insurance get direct-acting antiviral (DAA) treatment for hepatitis C within a year of diagnosis.
  
  • Treatment is lowest among patients in state-administered Medicaid plans, with less than 1 in 4 Medicaid recipients (23%) being treated within a year of diagnosis.
  
  o Additionally, Medicaid recipients in states that restrict access to hepatitis C treatment are 23% less likely to receive treatment than Medicaid recipients in states without restrictions.
  
  
• Subjects:
  COVID-19 Vaccines COVID-19/prevention & Control Vaccines, Synthetic
• Document Type:
  Press Release
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:6652326f065087084f60c67b5d8f683cdb10f397d5ef73c9eaf6fc5c611501e0
• Download URL:
  https://stacks.cdc.gov/view/cdc/120090/cdc_120090_DS1.pdf
• File Type:
  [PDF - 286.72 KB ]